Some of the best links we picked up around the internet

There are currently four clinical-stage gene-editing candidates in clinical trials for sickle cell disease, which affects millions of people worldwide...

In this roundup, we provide a summary of the ongoing gene-editing trials for beta thalassemia. This update includes trials sponsored by Vertex...

In this piece, we provide selected highlights from the 63rd American Society of Hematology annual meeting, held from December 11-14th 2021.

Some of the best links we picked up around the internet

Verve Therapeutics demonstrates preclinical proof-of-concept with support from Beam Therapeutics

Multiple new deals and developments and new base editor data from Intellia Therapeutics